28 August, Sophie Laurenson, PhD
https://www.clinicallabmanager.com
Immunotherapy describes a set of therapies that leverage the capacity of the immune system to combat disease. Recent clinical successes of immunotherapies have made this an active field of research. It is considered one of the […]
5 September 2019
Using the tools of biotechnology and immunology to help transforming cancer from a fatal to a manageable — or even curable – disease holds profound benefits to individual patients and the […]
By Leigh Dayton, 2 September 2019
Cartherics has been invited to present at the prestigious Cell & Gene Meeting on the Mesa https://www.meetingonthemesa.com/ in Carlsbad, California in October. The meeting is the sector’s leading annual conference, bringing senior industry executives together with the scientific community to advance research into cell-based therapies.
The meeting covers a variety […]
CAR-T immunotherapy involves genetically engineering T-cells with chimeric antigen receptors (CARs). FLOW cytometry uses antibodies tagged with fluorescent markers that bind to specific cell receptors. The labelled cells are then fed through a series of lasers and profiled using software such as FLOWLOGIC. FLOW cytometry works to […]
A student development evening was held again this year on 26 August 2019 at Monash University Clayton where Professor Graham Jenkin (Cartherics’ Education Officer) represented us. More on our PhD projects on our Education Opportunities page.
Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That’s why a small cadre of patients known as elite controllers has long fascinated researchers: Their immune system alone naturally suppresses HIV for decades without drugs. Now one team, inspired by success in mice, hopes to endow HIV-infected people […]
Despite the recent […]
https://www.premier.vic.gov.au/car-t-cell-cancer-therapy-to-save-lives/
The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients
The Victorian and Commonwealth Governments have worked together to bring the revolutionary, life-saving new […]
The Age, 28 July 2019
By Melissa Cunningham
Former SeaChange actor Tom Long was on the brink of death when he boarded a flight to the United States in April to take part in a medical trial for terminal blood cancer.
He arrived in Seattle with sunken cheeks and a body ravaged by chemotherapy. Weighing a little more […]
As of July, the number of scientists sharing the work load in Cartherics’ laboratory hit an even dozen. That’s thanks to Research Fellow and haematologist Madeline Cao who joined the team from CSIRO where she worked on haematopoietic stem cells with Susie Nilsson’s group.
At Cartherics her focus is […]
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
